Spero Therapeutics Inc (SPRO)
1.025
-0.02
(-2.38%)
USD |
NASDAQ |
Jan 08, 11:59
Spero Therapeutics Total Long Term Debt (Quarterly): 0.00 for Sept. 30, 2024
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| CytomX Therapeutics Inc | 0.00 |
| Castle Biosciences Inc | 10.02M |
| Arbutus Biopharma Corp | 0.00 |
| PTC Therapeutics Inc | 285.11M |
| Equillium Inc | 0.00 |